(ABR) Arbor Realty Trust - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0389231087
Stock: Real Estate Loans, Mortgage Finance, Equity Investments, Securities
Total Rating 40
Risk 81
Buy Signal -0.80
| Risk 5d forecast | |
|---|---|
| Volatility | 50.4% |
| Relative Tail Risk | -5.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -47.06 |
| Character TTM | |
|---|---|
| Beta | 0.903 |
| Beta Downside | 0.514 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.72% |
| CAGR/Max DD | 0.00 |
EPS (Earnings per Share)
Revenue
Description: ABR Arbor Realty Trust March 05, 2026
Arbor Realty Trust (ABR) is a real estate investment trust (REIT) focused on structured finance assets within the multifamily, single-family rental, and commercial real estate sectors in the United States. REITs are legally required to distribute a significant portion of their taxable income to shareholders.
The company operates through two segments: Structured Business and Agency Business. Its primary investments include bridge and mezzanine loans, preferred and direct equity, and real estate-related joint ventures. The business model involves providing short-term capital solutions for property acquisition and various forms of subordinate financing.
ABR also originates, sells, and services multifamily mortgage loans, often through conduit/commercial mortgage-backed securities programs. This involves packaging loans for sale to institutional investors.
To further your research, consider exploring ValueRay for detailed financial metrics and performance trends.
Headlines to watch out for
- Interest rate fluctuations impact loan demand and profitability
- Multifamily and commercial real estate market health drives asset performance
- Loan origination volume directly affects revenue growth
- Regulatory changes to REITs or real estate lending pose risks
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 148.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.85 > 1.0 |
| NWC/Revenue: -419.8% < 20% (prev 1.39k%; Δ -1.81k% < -1%) |
| CFO/TA 0.03 > 3% & CFO 372.4m > Net Income 148.8m |
| Net Debt (10.57b) to EBITDA (919.4m): 11.49 < 3 |
| Current Ratio: 0.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (212.5m) vs 12m ago 3.27% < -2% |
| Gross Margin: 92.15% > 18% (prev 0.90%; Δ 9.12k% > 0.5%) |
| Asset Turnover: 7.57% > 50% (prev 4.65%; Δ 2.92% > 0%) |
| Interest Coverage Ratio: 1.25 > 6 (EBITDA TTM 919.4m / Interest Expense TTM 701.8m) |
Altman Z'' -1.63
| A: -0.31 (Total Current Assets 482.9m - Total Current Liabilities 4.93b) / Total Assets 14.49b |
| B: -0.01 (Retained Earnings -136.6m / Total Assets 14.49b) |
| C: 0.06 (EBIT TTM 878.4m / Avg Total Assets 13.99b) |
| D: -0.01 (Book Value of Equity -134.6m / Total Liabilities 11.43b) |
| Altman-Z'' Score: -1.63 = D |
Beneish M
| DSRI: 0.00 (Receivables 6.53m/10.89b, Revenue 1.06b/627.5m) |
| GMI: 0.98 (GM 92.15% / 90.07%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.69 (Revenue 1.06b / 627.5m) |
| TATA: -0.02 (NI 148.8m - CFO 372.4m) / TA 14.49b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ABR shares?
As of March 14, 2026, the stock is trading at USD 7.98 with a total of 3,107,042 shares traded.
Over the past week, the price has changed by -8.51%, over one month by +2.99%, over three months by -5.12% and over the past year by -28.07%.
Over the past week, the price has changed by -8.51%, over one month by +2.99%, over three months by -5.12% and over the past year by -28.07%.
Is ABR a buy, sell or hold?
Arbor Realty Trust has received a consensus analysts rating of 2.75.
Therefor, it is recommend to hold ABR.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the ABR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.9 | 11.3% |
| Analysts Target Price | 8.9 | 11.3% |
ABR Fundamental Data Overview March 14, 2026
P/E Trailing = 15.5179
P/E Forward = 11.7371
P/S = 3.3764
P/B = 0.7235
P/EG = 1.6489
Revenue TTM = 1.06b USD
EBIT TTM = 878.4m USD
EBITDA TTM = 919.4m USD
Long Term Debt = 5.90b USD (from longTermDebt, last quarter)
Short Term Debt = 4.93b USD (from shortTermDebt, last quarter)
Debt = 11.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.57b USD (from netDebt column, last quarter)
Enterprise Value = 12.41b USD (1.84b + Debt 11.05b - CCE 482.9m)
Interest Coverage Ratio = 1.25 (Ebit TTM 878.4m / Interest Expense TTM 701.8m)
EV/FCF = 33.32x (Enterprise Value 12.41b / FCF TTM 372.4m)
FCF Yield = 3.00% (FCF TTM 372.4m / Enterprise Value 12.41b)
FCF Margin = 35.13% (FCF TTM 372.4m / Revenue TTM 1.06b)
Net Margin = 14.04% (Net Income TTM 148.8m / Revenue TTM 1.06b)
Gross Margin = 92.15% ((Revenue TTM 1.06b - Cost of Revenue TTM 83.2m) / Revenue TTM)
Gross Margin QoQ = 91.41% (prev 93.99%)
Tobins Q-Ratio = 0.86 (Enterprise Value 12.41b / Total Assets 14.49b)
Interest Expense / Debt = 1.63% (Interest Expense 180.3m / Debt 11.05b)
Taxrate = 13.84% (4.20m / 30.3m)
NOPAT = 756.9m (EBIT 878.4m * (1 - 13.84%))
Current Ratio = 0.10 (Total Current Assets 482.9m / Total Current Liabilities 4.93b)
Debt / Equity = 3.74 (Debt 11.05b / totalStockholderEquity, last quarter 2.95b)
Debt / EBITDA = 11.49 (Net Debt 10.57b / EBITDA 919.4m)
Debt / FCF = 28.38 (Net Debt 10.57b / FCF TTM 372.4m)
Total Stockholder Equity = 2.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.06% (Net Income 148.8m / Total Assets 14.49b)
RoE = 4.99% (Net Income TTM 148.8m / Total Stockholder Equity 2.98b)
RoCE = 9.89% (EBIT 878.4m / Capital Employed (Equity 2.98b + L.T.Debt 5.90b))
RoIC = 8.88% (NOPAT 756.9m / Invested Capital 8.52b)
WACC = 2.52% (E(1.84b)/V(12.89b) * Re(9.24%) + D(11.05b)/V(12.89b) * Rd(1.63%) * (1-Tc(0.14)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.36%
[DCF] Terminal Value 84.88% ; FCFF base≈408.1m ; Y1≈356.7m ; Y5≈288.7m
[DCF] Fair Price = N/A (negative equity: EV 8.76b - Net Debt 10.57b = -1.81b; debt exceeds intrinsic value)
EPS Correlation: -58.87 | EPS CAGR: -14.74% | SUE: 2.05 | # QB: 2
Revenue Correlation: 58.91 | Revenue CAGR: 21.27% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.16 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=0.70 | Chg7d=-0.138 | Chg30d=-0.138 | Revisions Net=-2 | Growth EPS=-34.6% | Growth Revenue=+2.5%
EPS next Year (2027-12-31): EPS=1.00 | Chg7d=-0.028 | Chg30d=-0.028 | Revisions Net=-2 | Growth EPS=+42.4% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.8% (Discount Rate 9.2% - Earnings Yield 6.4%)
[Growth] Growth Spread = -15.9% (Analyst -13.1% - Implied 2.8%)
P/E Forward = 11.7371
P/S = 3.3764
P/B = 0.7235
P/EG = 1.6489
Revenue TTM = 1.06b USD
EBIT TTM = 878.4m USD
EBITDA TTM = 919.4m USD
Long Term Debt = 5.90b USD (from longTermDebt, last quarter)
Short Term Debt = 4.93b USD (from shortTermDebt, last quarter)
Debt = 11.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.57b USD (from netDebt column, last quarter)
Enterprise Value = 12.41b USD (1.84b + Debt 11.05b - CCE 482.9m)
Interest Coverage Ratio = 1.25 (Ebit TTM 878.4m / Interest Expense TTM 701.8m)
EV/FCF = 33.32x (Enterprise Value 12.41b / FCF TTM 372.4m)
FCF Yield = 3.00% (FCF TTM 372.4m / Enterprise Value 12.41b)
FCF Margin = 35.13% (FCF TTM 372.4m / Revenue TTM 1.06b)
Net Margin = 14.04% (Net Income TTM 148.8m / Revenue TTM 1.06b)
Gross Margin = 92.15% ((Revenue TTM 1.06b - Cost of Revenue TTM 83.2m) / Revenue TTM)
Gross Margin QoQ = 91.41% (prev 93.99%)
Tobins Q-Ratio = 0.86 (Enterprise Value 12.41b / Total Assets 14.49b)
Interest Expense / Debt = 1.63% (Interest Expense 180.3m / Debt 11.05b)
Taxrate = 13.84% (4.20m / 30.3m)
NOPAT = 756.9m (EBIT 878.4m * (1 - 13.84%))
Current Ratio = 0.10 (Total Current Assets 482.9m / Total Current Liabilities 4.93b)
Debt / Equity = 3.74 (Debt 11.05b / totalStockholderEquity, last quarter 2.95b)
Debt / EBITDA = 11.49 (Net Debt 10.57b / EBITDA 919.4m)
Debt / FCF = 28.38 (Net Debt 10.57b / FCF TTM 372.4m)
Total Stockholder Equity = 2.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.06% (Net Income 148.8m / Total Assets 14.49b)
RoE = 4.99% (Net Income TTM 148.8m / Total Stockholder Equity 2.98b)
RoCE = 9.89% (EBIT 878.4m / Capital Employed (Equity 2.98b + L.T.Debt 5.90b))
RoIC = 8.88% (NOPAT 756.9m / Invested Capital 8.52b)
WACC = 2.52% (E(1.84b)/V(12.89b) * Re(9.24%) + D(11.05b)/V(12.89b) * Rd(1.63%) * (1-Tc(0.14)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.36%
[DCF] Terminal Value 84.88% ; FCFF base≈408.1m ; Y1≈356.7m ; Y5≈288.7m
[DCF] Fair Price = N/A (negative equity: EV 8.76b - Net Debt 10.57b = -1.81b; debt exceeds intrinsic value)
EPS Correlation: -58.87 | EPS CAGR: -14.74% | SUE: 2.05 | # QB: 2
Revenue Correlation: 58.91 | Revenue CAGR: 21.27% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.16 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=0.70 | Chg7d=-0.138 | Chg30d=-0.138 | Revisions Net=-2 | Growth EPS=-34.6% | Growth Revenue=+2.5%
EPS next Year (2027-12-31): EPS=1.00 | Chg7d=-0.028 | Chg30d=-0.028 | Revisions Net=-2 | Growth EPS=+42.4% | Growth Revenue=+2.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.8% (Discount Rate 9.2% - Earnings Yield 6.4%)
[Growth] Growth Spread = -15.9% (Analyst -13.1% - Implied 2.8%)